In vivo, the linear correlation between BLMH expression and tumor complete response rate was moderate (R = 0.50), supporting the hypothesis that BLMH can serve as a partial biological predictive factor for tumor responsiveness to ECT; however, it is not the only predictive factor involved in the response. Here, BLMH is linked to neoplasm.